购物车
- 全部删除
- 您的购物车当前为空
Icotrokinra (JNJ-77242113) 是一种选择性IL-23受体拮抗剂,其口服效果显著.该化合物对人类IL-23受体hIL-23R显示出高度亲和力,Kd值达到7.1 pM.Icotrokinra 能够在PMBC中抑制由IL-23触发的STAT3磷酸化,IC50为5.6 pM,并能显著抑制IFNγ与IL-17A的产生.此外,在大鼠的TNBS诱导的结肠炎模型中,Icotrokinra表现出强大的抗炎效果.
Icotrokinra (JNJ-77242113) 是一种选择性IL-23受体拮抗剂,其口服效果显著.该化合物对人类IL-23受体hIL-23R显示出高度亲和力,Kd值达到7.1 pM.Icotrokinra 能够在PMBC中抑制由IL-23触发的STAT3磷酸化,IC50为5.6 pM,并能显著抑制IFNγ与IL-17A的产生.此外,在大鼠的TNBS诱导的结肠炎模型中,Icotrokinra表现出强大的抗炎效果.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Icotrokinra (JNJ-77242113) is an orally effective selective antagonist of the IL-23 receptor (IL-23 receptor), demonstrating high affinity with a dissociation constant (Kd) of 7.1 pM for the human IL-23 receptor (hIL-23R). It inhibits IL-23-induced STAT3 phosphorylation in PBMC with an IC50 of 5.6 pM and suppresses the production of IFNγ and IL-17A at the epidermal level induced by IL-23. Additionally, Icotrokinra exhibits anti-inflammatory activity in a rat model of TNBS-induced colitis. |
靶点活性 | IL-23:7.1 pM (Kd) |
别名 | PN-235, JNJ-77242113, JNJ-2113 |
分子量 | 1898.17 |
分子式 | C90H120N20O22S2 |
CAS No. | 2763602-16-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.